John P. Schmid insider trades: BlossomHill Therapeutics (BLSM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
and 4 more companies
Open-market buys and sales
27 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | BLSM | ↑ Buy | 6,000 | $16.00 | $96K | Direct | Aug 10, 2026 (0d) |
| Mar 30, 2026 | ANAB | ↓ Sell | 20,645 | $56.11 | $1.2M | Direct | Apr 1, 2026 (2d) |
| Aug 12, 2024 | XERS | ↑ Buy | 4,515 | $2.25 | $10K | By: The Schmid Family Trust dated August | Aug 13, 2024 (1d) |
| Aug 9, 2024 | XERS | ↑ Buy | 4,285 | $2.37 | $10K | By: The Schmid Family Trust dated August | Aug 12, 2024 (3d) |
| May 10, 2024 | XERS | ↑ Buy | 5,400 | $1.91 | $10K | By: The Schmid Family Trust dated August | May 10, 2024 (0d) |
| Mar 25, 2024 | DSGN | ↑ Buy | 26,965 | $3.70 | $100K | By Schmid Family Trust U/A dated 8-15-17 | Mar 25, 2024 (0d) |
| Mar 14, 2024 | XERS | ↑ Buy | 4,500 | $2.16 | $10K | By: The Schmid Family Trust dated August | Mar 14, 2024 (0d) |
| Nov 16, 2023 | XERS | ↑ Buy | 6,500 | $1.51 | $10K | By: The Schmid Family Trust dated August | Nov 17, 2023 (1d) |
| Jun 22, 2012 | TSRX | ↓ Sell | 1,800 | $6.00 | $11K | Direct | Jun 25, 2012 (3d) |
| Mar 1, 2012 | TSRX | ↓ Sell | 500 | $5.04 | $3K | Direct | Mar 2, 2012 (1d) |
| Feb 2, 2012 | TSRX | ↓ Sell | 500 | $5.63 | $3K | Direct | Feb 6, 2012 (4d) |
| Jan 3, 2012 | TSRX | ↓ Sell | 700 | $7.28 | $5K | Direct | Jan 4, 2012 (1d) |
| Dec 1, 2011 | TSRX | ↓ Sell | 700 | $7.50 | $5K | Direct | Dec 2, 2011 (1d) |
| Nov 7, 2011 | TSRX | ↓ Sell | 100 | $7.00 | $700 | Direct | Nov 8, 2011 (1d) |
| Nov 1, 2011 | TSRX | ↓ Sell | 600 | $6.75 | $4K | Direct | Nov 1, 2011 (0d) |
| Oct 26, 2011 | TSRX | ↓ Sell | 200 | $7.00 | $1K | Direct | Oct 27, 2011 (1d) |
| Oct 3, 2011 | TSRX | ↓ Sell | 600 | $6.33 | $4K | Direct | Oct 4, 2011 (1d) |
| Sep 1, 2011 | TSRX | ↓ Sell | 600 | $6.60 | $4K | Direct | Sep 2, 2011 (1d) |
| Aug 1, 2011 | TSRX | ↓ Sell | 1,200 | $8.85 | $11K | Direct | Aug 2, 2011 (1d) |
| Jul 20, 2011 | TSRX | ↓ Sell | 100 | $8.00 | $800 | Direct | Jul 21, 2011 (1d) |
| Jul 1, 2011 | TSRX | ↓ Sell | 700 | $7.93 | $6K | Direct | Jul 5, 2011 (4d) |
| Jun 1, 2011 | TSRX | ↓ Sell | 800 | $7.90 | $6K | Direct | Jun 1, 2011 (0d) |
| May 16, 2011 | TSRX | ↓ Sell | 400 | $8.00 | $3K | Direct | May 18, 2011 (2d) |
| May 5, 2011 | TSRX | ↓ Sell | 200 | $7.00 | $1K | Direct | May 9, 2011 (4d) |
| May 3, 2011 | TSRX | ↓ Sell | 700 | $5.73 | $4K | Direct | May 3, 2011 (0d) |
| Apr 1, 2011 | TSRX | ↓ Sell | 500 | $5.66 | $3K | Direct | Apr 4, 2011 (3d) |
| Mar 1, 2011 | TSRX | ↓ Sell | 1,400 | $7.04 | $10K | Direct | Mar 3, 2011 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BLSM insiders
Open-market trades in the last 12 months
About John P. Schmid's insider trades
John P. Schmid is an insider at BlossomHill Therapeutics (BLSM). Since Mar 1, 2011, John has reported 7 open-market purchases worth $246K and 20 sales worth $1.2M on SEC Form 4. In the last 12 months: 1 buy ($96K) and 1 sale ($1.2M).
Their filings also include grants and awards (42 filings), option exercises (7 filings), shares returned to the company (6 filings), other transactions (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BLSM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.